The paper compared calprotectin, lactate dehydrogenase (LDH) and potassium levels in case-matched ascites specimens transferred and stored in clot activator, K2EDTA and lithium heparin tubes and centrifuged at 400 g, 1,500 g or 3,000 g.
Preanalytical study concerning the influence of tube type and centrifugation conditions on the concentration of calprotectin in ascites.
Dorotić A, Siter-Kuprešanin M, Čičak H, Saračević A, Vuljanić D, Troskot Perić R, Alfirević I
Purpose
Conclusion
Calprotectin levels were highest in ascites from the clot activator tubes that were centrifuged at 1,500 g for 15 min (Control, median 0.349 mg/L). Compared to the control, calprotectin levels were significantly lower in K2EDTA ascites that were centrifuged at 400 g (median 0.121 mg/L, P<0.001), 1,500 g (median 0.162 mg/L, P<0.001) or 3,000 g (median 0.109 mg/L, P<0.001) for 15 min and in ascites from lithium heparin tubes that were centrifuged at 400 g for 15 min (median 0.186 mg/L, P<0.0001). Importantly, the bias in calprotectin levels relative to the control exceeded the 14% threshold for clinical significance for all specimens collected in K2EDTA or lithium heparin tubes, regardless of centrifugation speed, and when ascites in clot activator tubes were centrifuged at 400 or 3000 g for 15 min instead of 1,500 g. Potassium levels did not differ between ascites in clot activator and lithium heparin tubes (K2EDTA not compared), regardless of centrifugation speed. Lactate dehydrogenase (LDH) levels were lower in K2EDTA ascites centrifuged at 1,500 or 3,000 g (median 66 and 67 U/L) than in clot activator ascites centrifuged at 400 g, 1,500 g, or 3,000 g (median 68, 69 and 68 U/L, respectively; P=0.046). The authors concluded that calprotectin should be measured in ascites collected in clot activator tubes and centrifuged at 15,000 g for 15 min.
Studies (1)
Purpose
This study compared calprotectin, lactate dehydrogenase (LDH) and potassium levels in case-matched ascites transferred and stored in clot activator, K2EDTA and lithium heparin tubes and then centrifuged at 400 g, 1,500 g or 3,000 g. Ascites was collected from the lower left or right quadrant of the abdomen of twenty supine patients with advanced or suspected liver cirrhosis and patients with malignancies along with symptoms necessitating diagnostic paracentesis (abdominal pain, fever, encephalopathy, hypotension, renal failure, acidosis or peripheral leukocytosis). After collection, ascites was transferred in triplicate into K2EDTA tubes (lavender top), clot activator tubes (red top) and lithium heparin tubes (green top). Tubes were mixed and case-matched specimens were centrifuged at 400 g for 15 minutes, at 1,500 g for 15 minutes or at 3,000 g for 15 minutes. Calprotectin levels were measured using the Bühlmann fCAL turbo test. Levels of potassium and LDH were quantified using an auto-analyzer (potassium not measured in K2EDTA specimens). Data did not have a normal distribution, so statistical significance was evaluated using the Friedman test. A > 14% change in calprotectin levels relative to levels in the clot activator tube centrifuged at 15,000 g for 15 min (control) was considered clinically significant.
Summary of Findings
Calprotectin levels were highest in ascites from clot activator tubes centrifuged at 1,500 g for 15 min (control, median 0.349 mg/L). Compared to the control, calprotectin levels were significantly lower in ascites collected in K2EDTA tubes and centrifuged at 400 g (median 0.121 mg/L, P<0.001), 1,500 g (median 0.162 mg/L, P<0.001) or 3,000 g (median 0.109 mg/L, P<0.001) for 15 min and in lithium heparin ascites centrifuged at 400 g for 15 min (median 0.186 mg/L, P<0.0001). Importantly, the bias in calprotectin levels relative to the control exceeded the 14% threshold for clinical significance for all specimens collected in K2EDTA or lithium heparin tubes, regardless of centrifugation speed and for clot activator tubes centrifuged at 400 or 3,000 g for 15 min instead of 1,500 g. Potassium levels did not differ between ascites collected in clot activator and lithium heparin tubes (K2EDTA not compared), regardless of centrifugation speed. LDH levels were lower in K2EDTA ascites centrifuged at 1,500 or 3,000 g (median 66 and 67 U/L) than in clot activator ascites centrifuged at 400 g, 1,500 g, or 3,000 g (median 68, 69 and 68 U/L, respectively; P=0.046). The authors concluded that calprotectin should be measured in ascites collected in clot activator tubes and centrifuged at 15,000 g for 15 min.
Biospecimens
FluidAscitesPreservation Types
None (Fresh)Diagnoses
CirrhosisNeoplasticOtherOther diagnosesPlatforms
ProteinClinical chemistry/auto analyzerElectrolyte/MetalClinical chemistry/auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Anticoagulant Lithium heparinNonePotassium EDTABiospecimen Acquisition Type of collection container/solution Clot activator tubeK2EDTA tubeLithium heparin tubeBiospecimen Aliquots and Components Centrifugation Multiple speeds compared